Catalyst Wire Dossier Catalyst Wire Dossier

AFGen1

· TriVirum, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AFGen1, covering 2024-06-20 to 2024-06-20. Get the full timeline:

Most recent: Clinical Trial Update: Further Study of AFGen1 Clinical Performance

See pricing